Article Information
History
- March 4, 2022.
Article Versions
- Version 1 (June 21, 2021 - 06:36).
- Version 2 (August 19, 2021 - 09:55).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Beatrice Kennedy1,
- Hugo Fitipaldi2,
- Ulf Hammar1,
- Marlena Maziarz3,
- Neli Tsereteli2,
- Nikolay Oskolkov4,
- Georgios Varotsis1,
- Camilla A Franks3,
- Diem Nguyen1,
- Lampros Spiliopoulos3,5,
- Hans-Olov Adami6,7,8,
- Jonas Björk9,10,
- Stefan Engblom11,
- Katja Fall12,13,
- Anna Grimby-Ekman14,
- Jan-Eric Litton7,
- Mats Martinell15,16,
- Anna Oudin9,17,
- Torbjörn Sjöström18,
- Toomas Timpka19,
- Carole H Sudre20,21,22,
- Mark S Graham22,
- Julien Lavigne du Cadet23,
- Andrew T. Chan24,
- Richard Davies23,
- Sajaysurya Ganesh23,
- Anna May23,
- Sébastien Ourselin22,
- Joan Capdevila Pujol23,
- Somesh Selvachandran23,
- Jonathan Wolf23,
- Tim D Spector25,
- Claire J Steves25,
- Maria F Gomez3,ꭞ,
- Paul W Franks2,ꭞ and
- Tove Fall1,ꭞ,*
- 1Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Sweden
- 2Genetic and Molecular Epidemiology Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Lund University, Sweden
- 3Diabetic Complications Unit, Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden
- 4Department of Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund University, Sweden
- 5Skåne University Hospital, Malmö, Sweden
- 6Clinical Effectiveness Group, Institute of Health and Society, University of Oslo, Oslo, Norway
- 7Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
- 8Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- 9Division of Occupational and Environmental Medicine, Lund University, Sweden
- 10Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden
- 11Division of Scientific Computing, Department of Information Technology, Uppsala University, Sweden
- 12Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden
- 13Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- 14Biostatistics, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- 15Department of Public Health and Caring Sciences, Uppsala University, Sweden
- 16Primary Care and Health, Region Uppsala, Sweden
- 17Department of Public Health and Clinical Medicine, Section of Sustainable health, Umeå University, Sweden
- 18Novus International Group AB, Sweden
- 19Department of Medical and Health Sciences, Linköping University, Sweden
- 20MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK
- 21Centre for Medical Image Computing, University College London, London, UK
- 22School of Biomedical Engineering and Imaging Sciences, King’s College London, London, UK
- 23ZOE Limited
- 24Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- 25Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
- ↵*Corresponding author: Professor Tove Fall, EpiHubben, Uppsala University, 751 85 Uppsala, Sweden, tove.fall{at}medsci.uu.se
Posted March 04, 2022.
App-based COVID-19 syndromic surveillance and prediction of hospital admissions: The COVID Symptom Study Sweden
